Miao, Xin
Wu, Liviawati S.
Lin, Shun Xin Wang
Xu, Yan
Chen, Yang
Iwaki, Yuki
Kobos, Rachel
Stephenson, Tara
Kemmerer, Kristy
Uhlar, Clarissa M.
Banerjee, Arnob
Goldberg, Jenna D.
Trancucci, Danielle
Apte, Amit
Verona, Raluca
Pei, Lixia
Desai, Rachit
Hickey, Kathleen
Su, Yaming
Ouellet, Daniele
Samtani, Mahesh N.
Guo, Yue
Garfall, Alfred L.
Krishnan, Amrita
Usmani, Saad Z.
Zhou, Honghui
Girgis, Suzette
Funding for this research was provided by:
Janssen Research and Development
Article History
Accepted: 8 August 2023
First Online: 15 September 2023
Declarations
:
: This study was funded by Janssen Research & Development, LLC.
: Xin Miao, Liviawati S. Wu, Yuki Iwaki, Rachel Kobos, Tara Stephenson, Kristy Kemmerer, Clarissa M. Uhlar, Arnob Banerjee, Danielle Trancucci, Amit Apte, Raluca Verona, Lixia Pei, Rachit Desai, Kathleen Hickey, Yaming Su, Daniele Ouellet, Mahesh Samtani, and Yue Guo are employees of Janssen. Shun Xin Wang Lin is an employee of LinkiDose Medicine Co., Ltd. Yan Xu is an employee of Simcere Pharmaceuticals. Yang Chen is an employee of Daiichi Sankyo. Jenna D. Goldberg is an employee of Vividon and holds stock in Janssen. Alfred L. Garfall is a consultant for Janssen, GSK, and Amgen; has received research funding from Janssen, Novartis, Tmunity, and CRISPR Therapeutics; and is an independent data monitoring committee member for Janssen. Amrita Krishnan is a consultant for Adaptive, Janssen, Sanofi, BMS, Pfizer, and Regneron; is a current equity holder in BMS; has received research funding from Janssen; is a Speakers’ Bureau member for Takeda, GSK, and BMS; and is a member of the Board of Directors or advisory committee for Sutro. Saad Z. Usmani has served in a consulting or advisory role for Celgene, Amgen, Janssen, Takeda, GlaxoSmithKline, Karyopharm Therapeutics, AbbVie, Merck, Genentech, Gilead Sciences, and Bristol-Myers Squibb/Celgene; and has received research funding from Celgene, Array BioPharma, Janssen, Pharmacyclics, Sanofi, Bristol-Myers Squibb, Amgen, Seattle Genetics, Merck, Skyline Diagnostics, and GlaxoSmithKline. Honghui Zhou is an employee of Jazz Pharmaceuticals and owns stocks in Jazz Pharmaceuticals and Johnson & Johnson. Suzette Girgis is an employee of Jazz Pharmaceuticals and holds stocks in JNJ and BMS.
: The data sharing policy of Janssen Pharmaceutical Companies of Johnson & Johnson is available at ExternalRef removed. Although these data are not currently publicly available for sharing, requests for sharing can be sent to the Corresponding Author and will be evaluated on an individual basis.
: Each study site’s local independent ethics committee or institutional review board approved the study protocol. The study was conducted in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines. All patients provided written informed consent.